Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/CLBIO stock hub

STO/CLBIO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/CLBIOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

457.3M

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/CLBIO

In the news

Latest news · STO/CLBIO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-15.3

P25 n/aP50 n/aP75 n/a

ROIC-9.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/CLBIO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

SEK

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	13
Employees Change	-1%
Employees Change Percent	-7.14
Enterprise value	SEK 424.4M
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0006887451
Last refreshed	2026-05-10
Market cap	SEK 457.3M
Price	SEK 17.5
Price currency	SEK
Rev Per Employee	888,583.33x
Sector	Healthcare
Sic	2836
Symbol	sto/CLBIO
Website	https://www.corline.se

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.09%
EV Earnings	-30.01x
EV/FCF	-23.7x
EV/Sales	39.8x
FCF yield	-3.92%
P/B ratio	4.55x
P/S ratio	42.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-133.32%
EBITDA Margin	-132.39%
Gross margin	82.8%
Gross Profit	SEK 8.8M
Gross Profit Growth	-53.68%
Gross Profit Growth Q	-0.9%
Gross Profit Growth3 Y	-35.05%
Gross Profit Growth5 Y	-9.61%
Net Income	SEK -14.1M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-132.65%
Profit Margin	-132.65%
Profit Per Employee	SEK -1.2M
ROA	-8.65
Roa5y	-4.72
ROCE	-12.97
ROE	-15.35
Roe5y	-10.21
ROIC	-9.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.18%
Cagr1y	65.94%
Cagr3y	8.37%
Cagr5y	9.24%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	-50.29x
Revenue Growth Q	-12.19x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-35.89x
Revenue Growth5 Y	-10.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.1
Assets	SEK 116M
Cash	SEK 32.9M
Current Assets	SEK 24M
Current Liabilities	SEK 4.8M
Equity	SEK 100.4M
Interest Coverage	-14,216
Liabilities	SEK 15.5M
Long Term Assets	SEK 92M
Long Term Liabilities	SEK 10.7M
Net Cash	SEK 32.9M
Net Cash By Market Cap	SEK 7.19
Net Cash Growth	6.8%
Net Debt Equity	SEK -0.33
Tangible Book Value	SEK 26M
Tangible Book Value Per Share	SEK 1.01
WACC	5.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.41
Net Working Capital	SEK 1.7M
Quick ratio	6.13
Working Capital	SEK 34.6M
Working Capital Turnover	SEK 0.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	119.47%
1Y total return	65.88%
200-day SMA	16.38
3Y total return	27.27%
50-day SMA	15.87
50-day SMA vs 200-day SMA	50under200
5Y total return	55.56%
All Time High	31
All Time High Change	-43.55%
All Time High Date	2018-09-28
All Time Low	5.98
All Time Low Change	192.64%
All Time Low Date	2024-11-28
ATR	0.89
Beta	0.3
Beta1y	0.63
Beta2y	0
Ch YTD	6.71
High	17.6
High52	27.2
High52 Date	2025-09-30
High52ch	-35.66%
Low	15.6
Low52	9.48
Low52 Date	2025-05-23
Low52ch	84.6%
Ma50ch	10.24%
Price vs 200-day SMA	6.83%
RSI	64.01
RSI Monthly	59.59
RSI Weekly	56.71
Sharpe ratio	1.08x
Sortino ratio	2.35
Total Return	-13.4%
Tr YTD	6.71
Tr1m	8.03%
Tr1w	14.01%
Tr3m	9.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -14.2M
Operating margin	-133.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,303,800%
Shares Insiders	45.06%
Shares Institutions	16.65%
Shares Out	26,133,117
Shares Qo Q	3.98%
Shares Yo Y	13.4%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK -17.9M
Average Volume	16,469.5x
Bv Per Share	3.92
CAPEX	SEK -404,000
Ch10y	113.4
Ch1m	8.03
Ch1w	14.01
Ch1y	65.88
Ch3m	9.38
Ch3y	27.27
Ch5y	55.56
Ch6m	-10.03
Change	12.18%
Change From Open	12.18
Close	15.6
Days Gap	0
Depreciation Amortization	104,000
Dollar Volume	769,370
Earnings Date	2026-05-15
EBIT	SEK -14.2M
EBITDA	SEK -14.1M
EPS	SEK -0.57
F Score	2
FCF	SEK -17.9M
FCF EV Yield	-4.22x
FCF Per Share	SEK -0.69
Financing CF	39,877,000
Fiscal Year End	December
Founded	1,991
Investing CF	-1,202,000
Is Primary Listing	1
Last Earnings Date	2026-02-17
Last Report Date	2025-12-31
Ma150	17.3
Ma150ch	1.14%
Ma20	16.03
Ma20ch	9.17%
Net CF	21,167,000
Next Earnings Date	2026-05-15
Open	15.6
Position In Range	95
Ppne	162,000
Price Date	2026-05-08
Ptbv Ratio	17.59
Relative Volume	2.93x
Revenue	10,663,000x
Tr6m	-10.03%
Volume	43,964

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/CLBIO pay a dividend?

Capital-return profile for this ticker.

Performance

STO/CLBIO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/CLBIO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+16.7%

Share of float held by funds and institutions

Insider ownership

+45.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+13.4%

Negative means the company is buying back shares.

Technical

STO/CLBIO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.0

Neutral momentum band

Price vs 200-day MA

+6.8%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

1.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/CLBIO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/CLBIO stock rating?

sto/CLBIO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/CLBIO analysis?

The full report lives at /stocks/sto/CLBIO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/CLBIO?

The latest report frames sto/CLBIO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/CLBIO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.